BridgeBio Team
BridgeBio
Last updated: February 23, 2026
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. Biotech Life Sciences
Sequoia, Post-IPO, $1.1B valuation
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. Biotech Life Sciences
Sequoia, Post-IPO, $1.1B valuation
- IPO • Sequoia, Post-IPO, $1.1B valuation
Founder Intelligence Brief: BridgeBio Team
This profile is built to help readers move from a founder name to decision-ready context. BridgeBio Team is mapped to BridgeBio in the Startup category, with current stage context as Ipo. The primary operating market is San Francisco Bay Area, California, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $1.10B, with the latest mapped round as IPO (Sequoia, Post-IPO, $1.1B valuation). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Startup startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Startup industry routes and Ipo stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Ipo funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Startup.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About BridgeBio Team
Common questions people ask about this profile.
Who is BridgeBio Team?
BridgeBio Team is the founder profile listed on 100Xfounder for BridgeBio, tracked for market signals, company intelligence, and operator-level context.
What does BridgeBio do?
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. Biotech Life Sciences
Where is BridgeBio based?
BridgeBio is listed as operating from San Francisco Bay Area, California, USA.
What is the current funding stage of BridgeBio?
BridgeBio is currently categorized at Ipo on 100Xfounder. Funding signal: Sequoia, Post-IPO, $1.1B valuation
What is the latest funding round for BridgeBio?
The latest tracked round for BridgeBio is IPO Sequoia, Post-IPO, $1.1B valuation. Total tracked rounds: 1.
Is BridgeBio hiring right now?
Current hiring signal for BridgeBio: Open Roles.
Is BridgeBio Team's profile verified?
Yes. BridgeBio Team's profile is marked as verified on 100Xfounder as of July 23, 2026.
How can I connect with BridgeBio Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for bridgebio.com.
What technologies are associated with BridgeBio?
BridgeBio is associated with AWS, React, Python, and PostgreSQL based on current profile intelligence.